T1	Participants 325 401	Forty pregnant women were randomly allocated to control or treatment groups.
T2	Participants 119 316	In an attempt to investigate the prophylactic effect of a thromboxane A2 (TXA2) synthetase inhibitor on pregnant women with a high risk of preeclampsia, the following clinical study was undertaken.
